intestinal adenocarcinoma of the stomach
Showing 1 - 25 of 8,584
Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach
Active, not recruiting
- Adenocarcinoma of the Gastroesophageal Junction
- +12 more
- copper Cu 64-DOTA-trastuzumab
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Liver Metastases, Colorectal Cancer, Anal Canal Cancer Trial in São Paulo (SBRT)
Recruiting
- Liver Metastases
- +3 more
- SBRT
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de São Paulo
Dec 15, 2021
Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Philadelphia (Adenovirus
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +37 more
- Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021
Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- +7 more
-
Bronx, New YorkMontefiore Medical Center
Jan 29, 2021
Ethmoid Sinus Tumor, Adenocarcinoma, Circulating Tumor Cell Trial (Liquid biopsy)
Not yet recruiting
- Ethmoid Sinus Tumor
- +2 more
- Liquid biopsy
- (no location specified)
Oct 18, 2023
The Gastric HormonE BioMarkers of Preneoplastic Lesions Study
Not yet recruiting
- Stomach Neoplasm
- +2 more
- (no location specified)
Oct 16, 2023
Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)
Recruiting
- Gastric Cancer
- Apatinib
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023
Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland
Not yet recruiting
- Secondary Malignant Neoplasm of Retroperitoneum
- +2 more
- Intestinal, Multivisceral or Modified Multivisceral Transplantation
- +3 more
-
Cleveland, OhioCleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023
Advanced Gastric Adenocarcinoma Trial in Henan (camrelizumab)
Recruiting
- Advanced Gastric Adenocarcinoma
-
Henan, ChinaHenan Tumor Hospital
Oct 13, 2022
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in
Terminated
- Adenocarcinoma of the Esophagus
- +13 more
- oblimersen sodium
- +2 more
-
Bronx, New YorkMontefiore Medical Center
Jan 29, 2021
Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer Trial in San Francisco
Recruiting
- Stage IV Esophageal Adenocarcinoma
- +43 more
- Radiation Therapy (RT)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 29, 2022
Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)
Recruiting
- Gastric Cancer
- +10 more
- Docetaxel
- +3 more
-
Kyiv, UkraineNational Cancer Institute
Aug 31, 2023
stratification of High-risk Intestinal Metaplasia (GCEP2 Study)
Recruiting
- Stomach Neoplasm
- Blood Collection, processing and analyses
- +2 more
-
Stanford, California
- +7 more
Mar 13, 2023
Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)
Active, not recruiting
- Stomach Neoplasms
-
Shanghai, ChinaRenji Hospital
Apr 3, 2023
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +85 more
- Patient Monitoring System
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Sep 7, 2022
Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)
Recruiting
- Adenocarcinoma
- +8 more
- Radiotherapy targeted to the primary lesion
- +7 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 7, 2023
Gastric Cancer Trial in Chang chun
Not yet recruiting
- Gastric Cancer
-
Chang chun, Ji Lin, Chinathe First Hospital of Jilin University
Oct 6, 2023
Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)
Recruiting
- Adenocarcinoma of Stomach
- Gentuximab Injection
- Gentuximab Injection Placebo
-
Shanghai, Shanghai, ChinaShanghai Dongfang Hospital
Jun 16, 2023
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Jul 25, 2023
Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)
Not yet recruiting
- Gastric Cancer
- S-1, Oxaliplatin, Cadonilimab
- (no location specified)
Jul 10, 2023
Stomach Tumors Trial in Wuhan (Fruquintinib, Sintilimab)
Not yet recruiting
- Stomach Neoplasms
-
Wuhan, Hubei, ChinaWuhan Union Hospital, China
Nov 22, 2022
Atrophic Gastritis, Intestinal Metaplasia, Gastric Dysplasia Trial in Porto (Upper gastrointestinal endoscopy)
Recruiting
- Atrophic Gastritis
- +3 more
- Upper gastrointestinal endoscopy
-
Porto, PortugalIPO-Porto
Mar 29, 2022
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Recruiting
- Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
- +44 more
- Best Practice
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 3, 2021
Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- TRK-950
- +2 more
-
Chuo Ku, JapanOsaka International Cancer Institute
Sep 14, 2023
A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach
Completed
- Gastric Cancer
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Mar 9, 2022